TC Medical(SH:600763) Sou Hu Cai Jing·2025-12-08 11:57Core Viewpoint - Tongce Medical (600763) has shown a slight decline in stock price and mixed capital flow, indicating potential investor caution and varying interest from different types of investors [1][2]. Group 1: Stock Performance - As of December 8, 2025, Tongce Medical closed at 41.74 CNY, down 0.1% with a turnover rate of 0.7% and a trading volume of 31,500 lots, amounting to a total transaction value of 132 million CNY [1]. - Over the past five days, the stock has experienced fluctuations in price and capital flow, with a notable net outflow of 1,098.88 million CNY on December 8, 2025, which accounted for 8.35% of the total transaction value [2]. Group 2: Financial Metrics - Tongce Medical's total market capitalization is 18.67 billion CNY, with a net asset value of 4.703 billion CNY and a net profit of 514 million CNY, ranking 8th, 12th, and 6th respectively within the medical services industry [3]. - The company reported a year-on-year revenue increase of 2.56% for the first three quarters of 2025, totaling 2.29 billion CNY, with a net profit of 514 million CNY, reflecting a 3.16% increase [3]. Group 3: Institutional Ratings - In the last 90 days, eight institutions have provided ratings for Tongce Medical, with five giving a "buy" rating and three an "increase" rating, while the average target price set by institutions is 52.88 CNY [4].